Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.140
+0.020 (1.79%)
At close: Jun 26, 2026, 4:00 PM EDT
1.130
-0.010 (-0.88%)
After-hours: Jun 26, 2026, 7:50 PM EDT
Bionano Genomics Employees
As of December 31, 2025, Bionano Genomics had 97 total employees, including 95 full-time and 2 part-time employees. The number of employees decreased by 3 or -3.00% compared to the previous year.
Employees
97
Change (1Y)
-3
Growth (1Y)
-3.00%
Revenue / Employee
$296,268
Profits / Employee
-$325,732
Market Cap
13.08M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Harvard Bioscience | 339 |
| Jin Medical International | 273 |
| Retractable Technologies | 201 |
| Femasys | 54 |
| Nephros | 36 |
| NEXGEL | 19 |
| Zentek | 18 |
| Milestone Scientific | 15 |
BNGO News
- 4 days ago - Bionano Genomics appoints Alex Hastie as chief scientific officer - TheFly
- 4 days ago - Bionano Announces Hiring of Chief Scientific Officer - GlobeNewsWire
- 10 days ago - Bionano Genomics announces studies featuring OGM at 2026 conference - TheFly
- 10 days ago - Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption - GlobeNewsWire
- 17 days ago - Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic Disorders - GlobeNewsWire
- 4 weeks ago - Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures - GlobeNewsWire
- 4 weeks ago - Bionano Genomics announces OGM study of T-cell acute lymphoblastic leukemia - TheFly
- 4 weeks ago - Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia - GlobeNewsWire